A novel role for the cell cycle regulatory complex cyclin D1-CDK4 in gluconeogenesis

Tetsuya Hosooka1, Wataru Ogawa1

  • 1Division of Diabetes and Endocrinology Department of Internal Medicine Kobe University Graduate School of Medicine Kobe Japan.

Insights

Cyclin D1 suppresses liver glucose production in type 2 diabetes by inhibiting PGC1alpha activity via CDK4. This finding reveals a link between cell cycle regulation and energy metabolism control.

Area of Science:

  • Metabolic regulation
  • Cell cycle control
  • Type 2 Diabetes

Background:

  • Gluconeogenesis dysregulation is central to type 2 diabetes pathogenesis.
  • Molecular mechanisms controlling hepatic gluconeogenesis require further elucidation.

Purpose of the Study:

  • To investigate the role of cyclin D1 in regulating hepatic gluconeogenesis.
  • To explore the molecular pathway linking cell cycle and energy metabolism.

Main Methods:

  • The study focuses on the interaction between cyclin D1, CDK4, and PGC1alpha.
  • Investigated the phosphorylation of PGC1alpha by CDK4 and its effect on PGC1alpha activity.

Main Results:

  • Cyclin D1 was found to suppress hepatic gluconeogenesis.
  • This suppression occurs through CDK4-dependent phosphorylation of PGC1alpha, inhibiting its function.
  • The cyclin D1-CDK4 complex modulates PGC1alpha activity.

Conclusions:

  • Cyclin D1 acts as a suppressor of hepatic gluconeogenesis.
  • The cyclin D1-CDK4 pathway provides a crucial link between cell cycle progression and energy metabolism regulation via PGC1alpha.

Related Concept Videos

Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
7.0K
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
137.1K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.6K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
9.2K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.8K